CD8A and neoplasm: The same application of pre-activated allogeneic DCs in patients suffering from metastatic renal cell carcinoma, however, led to ambiguous results, with some patients having increased CD8+ T cell infiltration in the tumors and others showing no objective tumor response at all [104].